These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 2784941
1. Response of neoplasms of B cell lineage to the proliferative effects of B cell growth factor and the phorbol ester TPA. Kinney MC, Collins RD, Whitlock J, Cousar JB, Vogler LB. Am J Pathol; 1989 Apr; 134(4):913-23. PubMed ID: 2784941 [Abstract] [Full Text] [Related]
2. Stimulation of B-chronic lymphocytic leukemia populations by recombinant interleukin-4 and other defined growth-promoting agents. Ghaderi AA, Richardson P, Cardona C, Millsum MJ, Ling N, Gillis S, Ledbetter J, Gordon J. Leukemia; 1988 Mar; 2(3):165-70. PubMed ID: 3126369 [Abstract] [Full Text] [Related]
3. Detection and characterization of human high molecular weight B cell growth factor receptors on leukemic B cells in chronic lymphocytic leukemia. Uckun FM, Fauci AS, Chandan-Langlie M, Myers DE, Ambrus JL. J Clin Invest; 1989 Nov; 84(5):1595-608. PubMed ID: 2681271 [Abstract] [Full Text] [Related]
6. [Phenotypes of leukemic cells from chronic B cell leukemia and their proliferative responses to several kinds of mitogens or lymphokines: PHA or phorbol ester (TPA) induces a high responsibility to B cell growth factor (BCGF) in the leukemic cells]. Takeuchi H. Rinsho Ketsueki; 1988 Dec; 29(12):2241-9. PubMed ID: 3266763 [No Abstract] [Full Text] [Related]
7. The effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) on leukemic cells from chronic B cell leukemia. Tokumine Y, Waki K, Nishimori Y, Kuratsune H, Inoue R, Nakamura Y, Ueda E, Machii T, Kitani T. Leukemia; 1989 Jul; 3(7):516-21. PubMed ID: 2786598 [Abstract] [Full Text] [Related]
8. Induction of surface marker changes and monoclonal idiotypic immunoglobulin secretion in lymphoma/leukemia cells: comparative study with interleukin-1, interleukin-2, interleukin-4, 8-bromo-guanosine, pokeweed mitogen, and tetradecanoyl phorbol-13-acetate. Gazitt Y, Gangavalli A, Thurman GB. Mol Biother; 1989 Jul; 1(6):297-304. PubMed ID: 2610949 [Abstract] [Full Text] [Related]
13. Triggering of neoplastic B cells via surface IgM and the cell surface antigens CD20 and CDw40. Responses differ from normal blood B cells and are restricted to certain morphologic subsets. Beiske K, Clark EA, Holte H, Ledbetter JA, Smeland EB, Godal T. Int J Cancer; 1988 Oct 15; 42(4):521-8. PubMed ID: 2459071 [Abstract] [Full Text] [Related]
14. Low-molecular weight B cell growth factor (BCGF-12KD) as an autocrine growth factor in B cell chronic lymphocytic leukemia. Fournier S, Jackson J, Kumar A, King T, Sharma S, Biron G, Rubio M, Delespesse G, Sarfati M. Eur J Immunol; 1992 Jul 15; 22(7):1927-30. PubMed ID: 1623931 [Abstract] [Full Text] [Related]
15. Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody. Suzuki T, Butler JL, Cooper MD. J Immunol; 1985 Apr 15; 134(4):2470-6. PubMed ID: 2982946 [Abstract] [Full Text] [Related]
16. Lack of effect of colony-stimulating factors, interleukins, interferons, and tumor necrosis factor on the growth and differentiation of cultured Reed-Sternberg cells. Comparison with effects of phorbol ester and retinoic acid. Hsu SM, Hsu PL. Am J Pathol; 1990 Jan 15; 136(1):181-9. PubMed ID: 1688689 [Abstract] [Full Text] [Related]
17. Large granular lymphocytes from B-chronic lymphocytic leukemia patients inhibit normal B cell proliferation. Perri RT, Kay NE. Am J Hematol; 1989 Jul 15; 31(3):166-72. PubMed ID: 2500849 [Abstract] [Full Text] [Related]
18. Induction of human B cell proliferation and differentiation by the combination of phorbol ester and ionomycin. Roifman CM, Benedict SH, Cheung RK, Gelfand EW. Eur J Immunol; 1987 May 15; 17(5):701-6. PubMed ID: 3495445 [Abstract] [Full Text] [Related]